GNTA - Genta Incorporated

Your Recent Quotes: 0 | 0

Genta Incorporated

TRADE NOW Related Information and Financials
Price Glossary Definition
0.25 0.00
0.00%
11/21/08 3:59
Open
0.25
Prev Close
0.25
Volume
73,321
52 Wk. Range
0.10- 0.77
Year-to-Date Performance Glossary Definition
DOWN -28.98%
Latest Dividend
Dividend
N/A
Yield
0.00
Ex-Date
N/A
Price/Earnings Comparisons Glossary Definition
 
-0.26
 
0.00
 
12.60
GNTA
Sect. Av.
S&P 500
Market Cap
8,450,400
Outstanding Shares
36,741,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy GNTA Rating Report
Target Price (1Yr)
High
1.00
Revenue
600,000

Annual Dividend
Rate
0.00
Yield
0.00
Growth
12 Month
3 Year
CAGR
Revenue
-18.10
-0.96
-0.66
Net Income
N/A
-0.29
0.00
EPS
N/A
-0.68
0.00

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-27.59
8.62
-67.61
Earnings Per Share($)

12/2005
 
 
 
-0.12
12/2006
 
 
 
-2.52
12/2007
 
 
 
-0.79

Earnings
EBITDA
-29,696,000
Revenue
580,000
Outside Analyst Rating History

11/22/08
0
Buy
11/22/08
1
Hold
11/22/08
0
Sell

Jim Cramer Portfolio
Find out now if GNTA is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Compare This Stock
Latest Headlines
A health stock rebound? Plus, my take on Onyx and M&A speculation fun.

11:41AM 04/05/08

PDL BioPharma helped boost health care stocks Tuesday.

4:41PM 08/21/07

As the Dow hits a new high, money manager Ken Fisher explains why stocks will keep rallying in '07.

5:42PM 12/15/06

Genta plunges as regulators say its cancer treatment is not approvable.

1:55PM 12/15/06

Regulators say its proposed blood cancer treatment Genasense isn't approvable.

10:59AM 12/15/06

Chattem jumps on consumer-products purchase from Johnson & Johnson.

1:08PM 10/06/06

The FDA agrees to the design of a proposed trial for an experimental leukemia treatment.

10:47AM 10/06/06

The biotech falls 25% after it says it will sell 20 million shares.

10:13AM 09/20/06

Genta tumbles on a plan to sell shares.

9:28AM 09/20/06

As with other sectors, learning to read the charts of the biotechs can improve your odds.

3:19PM 09/07/06

Understanding the Market

Our Experts' Take at RealMoney
However, option traders boost January calls.

4:37PM 11/21/08

This market is producing a few stocks that could represent exceptional opportunities.

3:03PM 11/21/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading GNTA in his Action Alerts Plus Portfolio?

Premium Services